Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
COCP
Cocrystal Pharma
$1.22
Login to see Cocrystal Pharma (COCP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Trading below its fair value
Chart
$1.45 (-15.86%)
$1.7 (-28.24%)
$1.44 (-15.28%)
$2.1 (-41.90%)
COCP has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
COCP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Trading below its fair value
COCP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
COCP Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayCOCP Earnings
The TTM reflects 12-month period, providing review of COCP financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is COCP current stock price?
What are COCP stock strengths?
What risks are associated with COCP stock?
When is COCP next earnings report?
What is COCP market cap and volume?
What is COCP's current Stock IQ?
Should I buy COCP stock right now?
Is COCP a Strong Buy right now?
What does a 'Strong Buy' rating mean for COCP?
What does a 'Strong Sell' rating mean for COCP?
What factors influence COCP's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
COCP
Cocrystal Pharma
Current Price
$1.22
Stock Insights
Strengths
Trading below its fair value
Login to unlock Cocrystal Pharma (COCP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$1.45 (-15.86%)
$1.7 (-28.24%)
$1.44 (-15.28%)
$2.1 (-41.90%)
COCP Analysts Opinion
COCP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Trading below its fair value
COCP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
COCP Street view is unimpressive and have negative views on the near-term outlook
COCP has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
Average key support and resistance price levels.
Login to displayCOCP Earnings
The TTM data reflects the most recent 12-month period, providing overview of COCP financial performance.
COCP Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
COCP Latest Analysis
Cocrystal Pharma files to sell 5.74M shares of common stock for holders.
Fri Sep 19, 2025
COCP: CDI-988 Showcased at Calicivirus Conference. Direct Offering Raises Up to $13 Million. By Business UpdateCDI-988 Overview Presented at Calicivirus ConferenceOn September 12 2025 Cocrystal Pharma Inc. (NASDAQ:COCP) announced that its Presidents and Co-CEO Dr. Sam Lee presented an overview of the companys lead pan-viral protease inhibitor CDI-988 at the 9th International Calicivirus Conference. A copy of the presentation can be found . CDI-988 is being developed as a treatment for both coron
Wed Sep 17, 2025
Cocrystal Pharma Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules. $4.7 million upfront with up to an additional approximately $8.3 million of potential aggregate gross proceeds upon the exercise in full of warrants
Mon Sep 15, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
COCP Stock trends
COCP Stock performance
COCP Stock analysis
COCP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings